(Q46064436)

19 December 2017

title

Factors influencing doctors' selection of dabigatran in non-valvular atrial fibrillation (English)

1 reference

19 December 2017

0 references

1 reference

Cindy Huang

1

1 reference

19 December 2017

Michele Siu

2

1 reference

19 December 2017

Lily Vu

3

1 reference

19 December 2017

Soo Wong

4

1 reference

19 December 2017

Jaekyu Shin

5

1 reference

19 December 2017

publication date

26 July 2012

1 reference

19 December 2017

Journal of Evaluation in Clinical Practice

published in

1 reference

19 December 2017

volume

19

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

938-943

1 reference

19 December 2017

Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2012.01886.X

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2012.01886.X

Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2012.01886.X

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2012.01886.X

Factors that influence prescribing decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2012.01886.X

Physician awareness of drug cost: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2012.01886.X

New medicines in primary care: a review of influences on general practitioner prescribing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2012.01886.X

Factors affecting the uptake of new medicines in secondary care - a literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2012.01886.X

Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2012.01886.X

Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2012.01886.X

Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2012.01886.X

Factors that influence prescribing within a therapeutic drug class.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2012.01886.X

Novel oral anticoagulants and their role in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2753.2012.01886.X

10.1111/J.1365-2753.2012.01886.X

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017